Search

everythinglearnresearchcommunity

for

Search:↓

Both mouse and rat models are effective for testing alopecia areata treatments.

Some stem cells in the body rarely divide, which could help create better treatments for diseases and aging.

Autophagy is important for human hair growth and health.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

A rare benign skin tumor showed unusual features of sebaceous and sweat glands, important for correct diagnosis.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Hydroxychloroquine helped improve scleromyxoedema in patients, but caused side effects in some.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

Lamivudine might reverse hair graying and needs more research for potential treatments.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Combining amino acid and stem cell therapy may help manage hepatocutaneous syndrome in dogs.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.